Nivolumab-induced organizing pneumonia in a melanoma patient

Japanese Journal of Clinical Oncology

Volumn 46, Issue 3, 2016, Pages 270-272

  Sano, Tasuku ^a   Uhara, Hisashi ^a   Mikoshiba, Yasutomo ^a   Kobayashi, Aya ^a   Uchiyama, Ryuhei ^a   Tateishi, Kazunari ^a   Yamamoto, Hiroshi ^a   Okuyama, Ryuhei ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Drug induced lung disease; Melanoma; Nivolumab; PD 1

Indexed keywords

DEXAMETHASONE; NIVOLUMAB; SURFACTANT PROTEIN D; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

AGED; ARTERIAL OXYGEN SATURATION; ARTICLE; BRAIN METASTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LUNG BIOPSY; LUNG LAVAGE; LUNG METASTASIS; MELANOMA; ORGANIZING PNEUMONIA; POLYMERASE CHAIN REACTION; SMOKING; THORAX RADIOGRAPHY; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHEMICALLY INDUCED; RADIOGRAPHY; SKIN NEOPLASMS; VAGINAL NEOPLASMS;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CRYPTOGENIC ORGANIZING PNEUMONIA; FEMALE; HUMANS; MELANOMA; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; VAGINAL NEOPLASMS;

EID: 84960358557     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyv199     Document Type: Article

References (8)

1. Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 2015;373:23-34.
2. Postow MA, Chesney J, Pavlick AC, Robert C, Grossmann K, McDermott D, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med 2015;372:2006-17.
3. Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 2015;372:320-30.
4. Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med 2015;372:2521-32.
5. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012;366:2443-54.
6. Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. NEngl J Med 2013;369:134-44.
7. Berthod G, Lazor R, Letovanec I, Romano E, Noirez L, Mazza Stalder J, et al. Pulmonary sarcoid-like granulomatosis induced by ipilimumab. J Clin Oncol 2012;30:e156-9.
8. Weber JS, Antonia SJ, Topalian SL, Schadendorf D, Larkin J, Sznol M, et al. Safety profile of nivolumab (NIVO) in patients (pts) with advanced melanoma (MEL): A pooled analysis. J Clin Oncol (Meeting Abstracts) 2015;33 (15 suppl):9018.